Dr. Andermann’s research focuses on how intestinal microbiome-host interactions impact infectious complications and other outcomes in patients with hematologic malignancies. Her goal is to develop microbiome-targeted therapies for the prevention and treatment of infectious diseases in these and other immunocompromised patient populations. She is an Infectious Diseases physician specializing in the care of patients with compromised immune systems. Dr. Andermann works together with a team of physicians and health professionals to provide the best and most compassionate care possible to those patients with cancer or who have undergone transplantation.
Microbiome Manipulation in Cancer: Are We Ready?
Cancer therapies are increasingly tailored to individual tumors, yet response may not only depend on treatment used but also the community of organisms living in and on our bodies known as the microbiome. This talk will address whether microbiome-altering therapies are still at the bench or ready for the bedside.